EXPOSED: The “Independent Interview” That Wasn’t — Inside Wellbeing International Foundation’s Self-Published PR Machine

For an organisation claiming to champion “innovation with integrity,” Wellbeing International Foundation appears remarkably comfortable presenting self-written promotional material as if it were independent journalism.

Our investigation has uncovered yet another example of what critics may describe as carefully engineered reputation management masquerading as media coverage.

The article in question, hosted on Vocal Media, is titled:

“A Chat with Andrew Chancellor, CEO at Wellbeing International Foundation”

At first glance, the piece appears to be a third-party interview conducted by an external publication. The layout, structure, and wording give the impression of an independent journalist sitting down with a healthcare entrepreneur to discuss the future of regenerative medicine.

But that impression quickly collapses under even the most basic scrutiny.

The First Red Flag: They Interviewed Themselves

The article is not written by an independent journalist.

It is not published by a recognised medical publication.

It is not investigative reporting.

It is not peer review.

It is not external scrutiny.

Instead, the article itself is openly credited to:

“By Wellbeing International Foundation”

The “creator” profile attached to the article is also listed as Wellbeing International Foundation.

In other words:

This appears to be Wellbeing International Foundation interviewing Wellbeing International Foundation about Wellbeing International Foundation.

Yet the formatting and presentation attempt to imitate legitimate media coverage.

This is not journalism.

It is advertorial marketing dressed up as independent validation.

And in the world of unregulated regenerative medicine, that distinction matters enormously.

The Language of Credibility — Without Evidence

Throughout the article, Andrew Chancellor makes sweeping statements about biologic therapies, regenerative medicine, and the future of healthcare.

But nowhere in the piece do readers find:

• Published clinical trial data

• Regulatory approvals

• Peer-reviewed evidence

• Named treating physicians

• Long-term safety data

• Independent outcome studies

• Adverse event reporting

• Scientific citations

• NHS adoption

• FDA approval references

• MHRA authorisation evidence

Instead, readers are given carefully polished phrases such as:

“Closing the gap between scientific discovery and everyday medicine.”

“Treatments that genuinely help people.”

“Natural biological repair.”

“Safe and meaningful progress.”

“Innovation with integrity.”

These are marketing slogans.

Not evidence.

“Research Has Repeatedly Shown…”

One of the most revealing sections of the article involves repeated references to unnamed “research.”

The interview claims:

“Research has repeatedly shown…”

But what research?

Where?

Published by whom?

Peer reviewed by which institution?

Under what regulatory framework?

None of this is provided.

There are no citations.

No links to trials.

No published datasets.

No controlled studies.

No evidence hierarchy whatsoever.

In legitimate scientific communication, extraordinary medical claims require extraordinary evidence.

Here, readers are simply asked to trust the company making the claims.

The Dangerous Use of Soft Medical Language

The article repeatedly relies on emotionally reassuring terminology:

• “Natural”

• “Autologous”

• “Healing”

• “Repair”

• “Cellular communication”

• “Support”

• “Wellness”

• “Longevity”

This style of wording is now common within parts of the global stem cell and exosome industry because it creates the appearance of science while often avoiding direct regulatory language.

But soft wording does not magically create clinical proof.

Calling something “natural” does not prove:

• safety,

• efficacy,

• legality,

• or scientific validity.

Many unproven treatments around the world use identical language patterns.

The Neurodegenerative Claims Problem

The interview strongly implies benefits relating to complex medical conditions and neurological degeneration.

This becomes especially concerning when compared against public regulatory warnings.

The FDA has repeatedly warned consumers that regenerative medicine products — including exosome-based therapies — are frequently marketed with unsupported claims relating to conditions such as:

• Parkinson’s disease

• Multiple sclerosis

• Alzheimer’s disease

• ALS

• Autism

• Stroke recovery

• Orthopaedic injury

• Chronic pain

According to the FDA:

“None of these products have been approved for the treatment of any neurological disorder.”

Yet Wellbeing’s own public marketing material references conditions including Parkinson’s disease and multiple sclerosis while promoting regenerative biologic concepts.

That contradiction is impossible to ignore.

Who Is Andrew Chancellor?

The article presents Andrew Chancellor as a visionary leader in regenerative medicine.

But publicly available information paints a very different picture.

According to Wellbeing International Foundation’s own website, Chancellor’s background is primarily rooted in:

• banking,

• recruitment,

• commercial strategy,

• and business development.

He is not publicly presented as:

• a licensed medical doctor,

• a neurologist,

• a clinical researcher,

• or a regulatory scientist.

That does not automatically invalidate his views.

But it does raise serious questions about why highly complex biologic therapies are being promoted through polished marketing interviews rather than transparent clinical evidence led by recognised medical specialists.

The Reputation Laundering Model

This investigation now identifies a recurring pattern commonly seen across controversial wellness and regenerative medicine operations:

Step 1:

Create promotional content internally.

Step 2:

Publish it on a third-party content platform.

Step 3:

Present it visually as media coverage.

Step 4:

Use the article as implied credibility.

Step 5:

Circulate the link across websites and social media as “press.”

To ordinary readers, the distinction is often invisible.

But to investigators, the structure is obvious.

The Most Important Question

If these therapies are as revolutionary as claimed…

Where is the evidence?

Where are the blinded studies?

Where are the published outcomes?

Where are the independent hospitals?

Where are the recognised regulators?

Where are the named medical leads?

Where are the peer-reviewed papers validating these claims?

Because without those things, what remains is not scientific transparency.

It is branding.

Final Analysis

The Vocal Media piece is not an independent interview.

It is a self-published promotional article created by the same organisation being praised within it.

The article attempts to borrow the appearance of journalism while providing none of journalism’s core safeguards:

• independence,

• scrutiny,

• challenge,

• verification,

• or balance.

In an industry already plagued by regulatory warnings, vulnerable patients, emotional sales tactics, and medically unverified claims, that should concern everyone.

Particularly families searching for hope.

And especially those being encouraged to spend large sums of money chasing treatments still lacking robust scientific validation.